Rijpkema A H, van der Sanden A A, Ruijs A H
Organon International, Registration Unit, Oss, Netherlands.
Maturitas. 1990 Sep;12(3):259-85. doi: 10.1016/0378-5122(90)90007-s.
There are strong indications that post-menopausal oestrogen replacement therapy has a protective effect on the cardiovascular system, due to changes in the lipid profile. There are also indications that the addition of progestogens to oestrogen therapy may negatively influence these effects on the lipid metabolism. The present survey was undertaken to provide a comprehensive summary of all the available data on the effect of combined oestrogen-progestogen treatment on the post-menopausal lipid profile published from 1984 onwards. It appears that many progestogens are capable of diminishing the beneficial changes induced by oestrogens. The ultimate effect depends on the type and daily dose of both the oestrogen and the progestogen component. Oestradiol or oestradiol valerate administered cyclically with progesterone or cyproterone acetate appear to have the most favourable impact on lipids and lipoproteins.
有强有力的迹象表明,绝经后雌激素替代疗法由于脂质谱的变化,对心血管系统有保护作用。也有迹象表明,在雌激素疗法中添加孕激素可能会对脂质代谢的这些作用产生负面影响。本次调查旨在全面总结1984年以来发表的关于雌激素 - 孕激素联合治疗对绝经后脂质谱影响的所有现有数据。似乎许多孕激素能够减少雌激素诱导的有益变化。最终效果取决于雌激素和孕激素成分的类型及每日剂量。与孕激素或醋酸环丙孕酮周期性联合使用的雌二醇或戊酸雌二醇似乎对脂质和脂蛋白有最有利的影响。